By otakuyassine3@gmail.com 
Alignment Healthcare, Inc. (NASDAQ:ALHC – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the twelve ratings firms that are currently covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating, seven have issued a buy rating and one has issued a strong buy rating on the company. The average twelve-month price target among analysts that have covered the stock in the last year is $14.83.
A number of equities research analysts recently commented on the stock. Bank of America increased their price objective on shares of Alignment Healthcare from $15.50 to $18.50 and gave the company a “buy” rating in a research note on Tuesday, March 4th. JPMorgan Chase & Co. increased their price objective on shares of Alignment Healthcare from $14.00 to $17.00 and gave the company a “neutral” rating in a research note on Thursday, March 6th. Barclays increased their price objective on shares of Alignment Healthcare from $8.00 to $9.00 and gave the company an “underweight” rating in a research note on Friday, February 28th. Stifel Nicolaus increased their price objective on shares of Alignment Healthcare from $16.00 to $18.00 and gave the company a “buy” rating in a research note on Friday, February 28th. Finally, William Blair reaffirmed an “outperform” rating on shares of Alignment Healthcare in a research note on Friday, February 28th.
View Our Latest Stock Analysis on ALHC
Insider Transactions at Alignment Healthcare
In other news, CEO John E. Kao sold 90,000 shares of the stock in a transaction dated Monday, January 13th. The shares were sold at an average price of $13.06, for a total transaction of $1,175,400.00. Following the transaction, the chief executive officer now directly owns 2,273,100 shares in the company, valued at $29,686,686. This represents a 3.81 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Robert L. Scavo sold 5,313 shares of the stock in a transaction dated Wednesday, March 12th. The stock was sold at an average price of $15.43, for a total transaction of $81,979.59. Following the transaction, the insider now owns 668,106 shares in the company, valued at approximately $10,308,875.58. The trade was a 0.79 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 1,799,454 shares of company stock worth $27,457,291 in the last three months. Company insiders own 6.60% of the company’s stock.
Institutional Inflows and Outflows
Several hedge funds have recently bought and sold shares of ALHC. Principal Financial Group Inc. raised its holdings in Alignment Healthcare by 1,335.1% in the third quarter. Principal Financial Group Inc. now owns 194,043 shares of the company’s stock valued at $2,294,000 after buying an additional 180,522 shares during the period. Royce & Associates LP purchased a new position in Alignment Healthcare in the third quarter valued at approximately $3,782,000. Connor Clark & Lunn Investment Management Ltd. purchased a new position in Alignment Healthcare in the third quarter valued at approximately $131,000. Intech Investment Management LLC purchased a new position in Alignment Healthcare in the third quarter valued at approximately $315,000. Finally, Charles Schwab Investment Management Inc. raised its holdings in Alignment Healthcare by 1.7% in the third quarter. Charles Schwab Investment Management Inc. now owns 839,695 shares of the company’s stock valued at $9,925,000 after buying an additional 13,865 shares during the period. Hedge funds and other institutional investors own 86.19% of the company’s stock.
Alignment Healthcare Price Performance
Shares of NASDAQ ALHC opened at $15.79 on Friday. The stock has a market cap of $3.03 billion, a price-to-earnings ratio of -20.51 and a beta of 1.49. Alignment Healthcare has a 52 week low of $4.46 and a 52 week high of $16.25. The company’s 50-day moving average price is $14.38 and its 200 day moving average price is $12.41. The company has a current ratio of 1.60, a quick ratio of 1.60 and a debt-to-equity ratio of 1.82.
About Alignment Healthcare
Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.
Read More
Receive News & Ratings for Alignment Healthcare Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Alignment Healthcare and related companies with MarketBeat.com’s FREE daily email newsletter.